ijms-logo

Journal Browser

Journal Browser

Novel Treatment Strategies for Head and Neck Cancer

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Oncology".

Deadline for manuscript submissions: 20 June 2025 | Viewed by 3128

Special Issue Editor


E-Mail
Guest Editor
Department of Clinical and Experimental Medicine, University of Foggia, Via Rovelli 50, 71122 Foggia, Italy
Interests: oral carcinoma; cancer stem cells; odontogenic tumours; oral mucositis; targeted therapies; oral potentially malignant disorders; microRNAs; long non-coding RNAs.

Special Issue Information

Dear Colleagues,

Despite advances in medical imaging and therapeutic approaches, the prognosis for patients with advanced head and neck cancer remains poor, with a 5-year survival rate still below 50%. Therefore, there is an urgent need for new treatment strategies to improve patient outcomes. The lack of substantial improvement in overall survival over the past three decades is largely due to the resistance of cancer cells to conventional radiotherapy and chemotherapy. To develop more effective therapeutic strategies, it is crucial to gain a deeper understanding of the molecular and cellular mechanisms underlying cancer initiation, progression, and recurrence.

This Special Issue focuses on new treatment strategies for head and neck cancer, aiming to enhance our molecular knowledge of these tumors to inform better therapies. We invite researchers to submit their original research articles and reviews that address innovative therapeutic approaches and treatment modalities for head and neck cancer. Topics of interest include, but are not limited to, targeted therapies, immunotherapies, combination treatments, personalized medicine, and advances in radiotherapy and chemotherapy. We also welcome studies on biomarkers for therapy response, drug resistance mechanisms, and clinical trials. Submissions may include experimental studies using in vitro and in vivo models, including patient-derived xenograft animal models, as well as biomarker analyses of patient saliva or other body fluids and research on tumor-derived microRNA or extracellular vesicles. Review articles that provide comprehensive overviews of current treatment strategies and future directions in the therapy of head and neck cancer are also encouraged.

Dr. Francesca Spirito
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • head and neck cancer
  • drug resistance
  • cancer initiation
  • biomarker

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

34 pages, 440 KiB  
Review
The Potential of Oncolytic Virotherapy in the Treatment of Head and Neck Cancer: A Comprehensive Review
by Francesca Spirito, Riccardo Nocini, Giorgio Mori, Massimo Albanese, Eleni A. Georgakopoulou, Gowri Sivaramakrishnan, Basel Khalil, Bruno Špiljak, Varun Surya, Deepika Mishra and Akhilanand Chaurasia
Int. J. Mol. Sci. 2024, 25(23), 12990; https://doi.org/10.3390/ijms252312990 - 3 Dec 2024
Viewed by 2639
Abstract
Head and neck cancer (HNC) represents a challenging oncological entity with significant morbidity and mortality rates. Despite advances in conventional therapies, including surgery, chemotherapy, and radiation therapy, the overall survival rates for advanced HNC remain suboptimal. In recent years, the emerging field of [...] Read more.
Head and neck cancer (HNC) represents a challenging oncological entity with significant morbidity and mortality rates. Despite advances in conventional therapies, including surgery, chemotherapy, and radiation therapy, the overall survival rates for advanced HNC remain suboptimal. In recent years, the emerging field of oncolytic virotherapy has gained attention as a promising therapeutic approach for various malignancies, including HNC. This review provides a comprehensive overview of the current understanding of oncolytic viruses (Ovs) in the context of HNC treatment, including their mechanisms of action, preclinical and clinical studies, challenges, and future directions. Future oncolytic virotherapy focuses on improving delivery and specificity through nanoparticle carriers and genetic modifications to enhance tumor targeting and immune response. Combining different OVs and integrating them with immunotherapies, such as checkpoint inhibitors, could overcome tumor resistance and improve outcomes. Personalized approaches and rigorous clinical trials are key to ensuring the safety and effectiveness of virotherapy in treating HNC. Full article
(This article belongs to the Special Issue Novel Treatment Strategies for Head and Neck Cancer)
Back to TopTop